▲ Peaking
Business
FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults
The FDA has approved Otsuka's Simtriyo (centanafadine), the first new-class ADHD medication for pediatric and adult patients in decades.
FDA Review A Clinical Path of the ADHD Medication
1 news trends Newsylist has tracked involving FDA Review A Clinical Path of the ADHD Medication — newest first.